You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1201 to 1225 of about 6010
Next 25
05/09/2019
Medicare proposal to cover Optune for Glioblastoma
Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System
The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner
Brain Tumor Awareness Month 2019 Webinar Series! 2 webinars in the next few days!
05/08/2019
Oncoceutics Invited to Present ONC201 at Public Advisory Committee Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee on June 20, 2019
05/05/2019
Reminder: Webinar tonight Sunday 5/5/19 7PM Eastern!
05/03/2019
Tmunity signs licensing deal for pediatric brain cancer immunotherapy
04/30/2019
Brain Tumor Awareness Month 2019 Webinar Series! (Schedule Change)
04/29/2019
Optune Open House
The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
04/27/2019
Leptomeningeal metastases in glioma
Correlation of Tumor Treating Fields dosimetry to survival outcomes in newly diagnosed glioblastoma: A large-scale numerical simulation-based analysis of data from the Phase 3 EF-14 randomized trial.
National Walk To End Brain Tumors
04/20/2019
Cancer and the dopamine D2 receptor: a pharmacological perspective.
04/18/2019
Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas
04/15/2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma - pooled analysis.
Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: a case report
04/11/2019
`I Love What I Do` - Internationally Renowned Brain Surgeon Dr. Linda Liau
04/09/2019
Case Report in the Journal of Neurosurgery Highlights Potential of ONC201 in H3 K27M-mutant DIPG
Optune Open Houses
04/03/2019
Phase 2 study of Val-083 with radiation therapy for newly diagnosed
New Glioblastoma Vaccine Shows Promising Results in Phase 1b Clinical Trial
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.